NCT06203600 2026-04-15Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialNational Cancer Institute (NCI)Phase 2/3 Recruiting224 enrolled
NCT06616584 2026-01-23Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)SWOG Cancer Research NetworkPhase 2/3 Recruiting378 enrolled